The Eurasian Journal of Medicine
Review

Intermittent Subcutaneous Injections of Apomorphine in Parkinson’s Disease

1.

Department of Neurology, Atatürk University Faculty of Medicine, Movement Disorders and Neuromodulation Center, Erzurum, Turkey

2.

Department of Neurology, Erciyes University Faculty of Medicine, Kayseri, Turkey

3.

Department of Neurology, Osmangazi University Faculty of Medicine, Eskişehir, Turkey

4.

Department of Neurology, İstanbul University İstanbul Faculty of Medicine, Behavioral Neurology and Movement Disorders Unit, İstanbul, Turkey

5.

Department of Neurology, Hacettepe University Faculty of Medicine, Ankara, Turkey

6.

Department of Neurology, Ankara University Faculty of Medicine, Ankara, Turkey

Eurasian J Med 2022; 54: Supplement S71-S76
DOI: 10.5152/eurasianjmed.2022.22134
Read: 88 Downloads: 25 Published: 01 December 2022

The intermittent subcutaneous injection of apomorphine is highly effective in the management of motor and non-motor symptoms of Parkinson’s disease. Although it has been shown that apomorphine injection can be safely used in selected cases at all stages of the disease, there is no consensus regarding intermittent administration strategies. This review aimed to discuss the indications for intermittent subcutaneous apomorphine use in clinical practice, possible side effects and their management, and contraindicated cases in light of the literature and to present practical recommendations for clinical practice.

Cite this article as: Ceylan M, Gültekin M, Durmaz Çelik N, Samanci B, Yalçin Çakmakli G, Yilmaz R. The role and use of intermittent subcutaneous injections of apomorphine in Parkinson’s disease. Eurasian J Med., 2022;54(Suppl. 1):S71-S76.

Files
EISSN 1308-8742